Abstract
O-linked N-acetylglucosamine (O-GlcNAc) is an evolutionarily conserved modification of nuclear pore proteins, signaling kinases, and transcription factors. The O-GlcNAc transferase (OGT) catalyzing O-GlcNAc addition is essential in mammals and mediates the last step in a nutrient-sensing “hexosamine-signaling pathway.” This pathway may be deregulated in diabetes and neurodegenerative disease. To examine the function of O-GlcNAc in a genetically amenable organism, we describe a putative null allele of OGT in Caenorhabditis elegans that is viable and fertile. We demonstrate that, whereas nuclear pore proteins of the homozygous deletion strain are devoid of O-GlcNAc, nuclear transport of transcription factors appears normal. However, the OGT mutant exhibits striking metabolic changes manifested in a ≈3-fold elevation in trehalose levels and glycogen stores with a concomitant ≈3-fold decrease in triglycerides levels. In nematodes, a highly conserved insulin-like signaling cascade regulates macronutrient storage, longevity, and dauer formation. The OGT knockout suppresses dauer larvae formation induced by a temperature-sensitive allele of the insulin-like receptor gene daf-2. Our findings demonstrate that OGT modulates macronutrient storage and dauer formation in C. elegans, providing a unique genetic model for examining the role of O-GlcNAc in cellular signaling and insulin resistance.
Keywords: nutrients, O-GlcNAc, signaling, diabetes mellitus
O-linked N-acetylglucosamine (O-GlcNAc) is a nucleocytoplasmic modification present throughout eukaryotic evolution with the possible exception of yeast (1, 2). Although many intracellular proteins such as nuclear pore components and transcription factors bear O-GlcNAc, the precise function of the modification is unknown. Evidence in mammals suggests a role for O-GlcNAc in the development of insulin resistance associated with noninsulin-dependent diabetes mellitus (3, 4). A number of lines of evidence also link O-GlcNAc to transcriptional regulation and neurodegeneration (1, 2). O-GlcNAc addition is partly driven by the levels of UDP-GlcNAc derived from the hexosamine biosynthetic pathway. This pathway is a nutrient-sensing pathway implicated in cellular signaling (1, 2). The uncertainty regarding the precise function of O-GlcNAc is perhaps to be expected given the many substrates modified by this glycan addition. Furthermore, O-GlcNAc is a dynamic modification; the levels of O-GlcNAc are maintained by the action of a glycosytransferase [O-linked GlcNAc transferase (OGT)] and a hexosaminidase (O-GlcNAcase) (1, 2). Mammalian O-GlcNAcase exists as two splice variants and is relatively specific for nucleocytoplasmic O-GlcNAc (1, 5, 6). The transferase, OGT, catalyzes the transfer of O-GlcNAc to Ser/Thr residues. This enzyme has been identified from a number of sources, including plants, human, rat, mouse, and the nematode Caenorhabditis elegans (7, 8). In plants, the OGT homolog Spindly is involved in plant-signaling pathways (9, 10). These evolutionarily conserved proteins share a similar overall structure; OGT is composed of multiple protein domains, including tetratricopeptide repeats and a catalytic domain composed of Rossman-like folds. We have recently solved the structure of the tetratricopeptide repeats of OGT and found that the repeats interact with target proteins via an Asn ladder similar to those found in importin α (11). The catalytic domain of OGT has also been suggested to have similarities to the glycogen phosphorylase superfamily (12).
In mammals, the gene encoding OGT is essential for embryonic and stem cell development and produces multiple transcripts resulting from alternative promoter usage and splicing (13–15). These OGT isoforms are differentially targeted to the nucleus and mitochondrion (15, 16). The presence of multiple isoforms and the embryonic lethality observed with mammalian knockouts has made analysis of the signaling functions of mammalian OGT difficult. Using a more targeted approach, OGT deletion has been linked to T cell apoptosis, neuronal τ hyperphosphorylation, and fibroblast growth arrest with altered expression of c-Fos, c-Jun, c-Myc, Sp1, and p27 (15). These studies strongly indicate that mammalian cells require a functional OGT allele.
To circumvent some of the problems encountered in examining mammalian OGT, we have chosen to examine the role of OGT in C. elegans. Previously, we identified a single gene (K04G7.3) encoding the 128-kDa C. elegans OGT protein (7). From existing EST data, this gene (ogt-1) appears to encode a single transcript corresponding to the nuclear/cytoplasmic form of OGT (7). Results obtained in our laboratory and others by using RNA interference (RNAi) suggested that interference with OGT expression resulted in no obvious developmental defect (7, 17, 18). These RNAi results suggested that it might be possible to study the signaling function of OGT without producing lethality.
In this report, we study an ogt-1 deletion strain of C. elegans that exhibits no obvious developmental phenotype in homozygous animals. We demonstrate that nuclear pore complexes in the ogt-1 mutant strain lack O-GlcNAc yet are capable of mediating the nuclear transport of transcription factors. Homozygous animals lacking ogt-1 activity appear to develop normally with little change in growth rate or fertility. However, we do observe a striking increase in the levels of trehalose and glycogen and an accompanying decrease in fat stores in the ogt-1 mutant strain. We also demonstrate that the ogt-1 deletion allele genetically suppresses a constitutive dauer mutation, demonstrating that OGT modulates dauer formation in the nematode. These data suggest that in C. elegans, O-GlcNAc addition may play a regulatory, but nonessential, role in nematode development. The observed modulation of the dauer pathway by OGT-1 suggests that the nematode may be a genetically amenable model for studying nutrient-driven insulin resistance.
Materials and Methods
Strains. The following strains were used in this study: WT N2 Bristol, RB653 [ogt-1(ok430)] generated and kindly provided by the C. elegans Gene Knockout Consortium (Oklahoma Medical Research Foundation, Oklahoma City), KM258 ogt-1(ok430) backcrossed four times, the integrated skn-1::gfp transgene (IS007) strain LD007 kindly provided by J. An and K. Blackwell (Joslin Diabetes Center, Boston), KM259 ogt-1(ok430); IS007, daf-2(e1370), and ogt-1(ok430) daf-2(e1370).
Characterization of the ogt-1(ok430) Deletion Allele. After backcrossing, single ogt-1(ok430) adult animals were lysed and used as a template to amplify the ogt-1 genomic region by using the original nested primers designed by the C. elegans Gene Knockout Consortium. The PCR products from several individual animal lysates were pooled and sequenced with primers spanning the region. Sequence analysis revealed that the ogt-1(ok430) allele resulted from a deletion of 1,094 bp of ogt-1 gene sequence from the beginning of exon 8 to the middle of exon 9. In addition to the deleted sequence, this region had an insertion of 141 bp derived from noncoding sequence from cosmid F54E7 located ≈1,500 kb from ogt-1 on LGIII. The inserted sequence results in an in-frame stop codon at the 5′ deletion breakpoint, resulting in a predicted truncated ogt-1 translation product of 454 aa compared with the WT protein that is 1,151 aa in length. The deletion allele was subsequently tracked by nested PCR by using the outside pair of primers MWK453 (CCACACTTCCCTGATGCCTAC) and consortium “inner left” (ACCTGTCCGAGACCATTCTG) and the inside pair of primers MWK456 (CTCTGCCAACCCACGCGGA) and MWK457 (TGAGCGTGATCTCCAATGAAG). The predicted ogt-1 mRNA in ogt-1(ok430) was confirmed by RT-PCR and sequencing.
Lipid Analysis. Lipids were extracted by the method of Folch et al. (19) after sonication of lyophilized nematode pellets in chloroform/methanol 2:1. After extraction, the lipids were subjected to two additional extractions in chloroform/methanol 2:1. Lipid fractions were then dried under nitrogen and analyzed by either TLC to separate lipid fractions [hexane/diethyl ether/acetic acid (70/30/1, vol/vol)] or quantitatively analyzed by HPLC. For HPLC, nonpolar lipids were separated basically as described (20). In brief, total lipids were dried under N2, resuspended in hexane, and injected onto a Zorbax CN (Agilent Technologies, Palo Alto, CA) 150 × 4.6 mm (5 μm) column. Mobile phase A was hexane and mobile phase B was tert-butyl methyl ether, and the flow rate was 1 ml/min. Solvent B was set at 3% for 3 min, increased to 20% by 12 min and 100% by 17 min, and held at 100% for 5 min. The column was allowed to reequilibrate with 3% solvent B for 5 min before the next injection. Lipids were detected with a PL-ELS 2100 evaporative light scattering detector (Polymer Laboratories, Amherst, MA) with an evaporator temperature of 90°C, nebulizer temperature of 50°C, and a gas (N2) flow rate of 2 liters per min. The peak containing triglycerides was identified by comparison to known standards (Sigma). Calibration for mass amounts was based on an external standard.
Carbohydrate Analysis. C. elegans strains grown in large quantities were rinsed with water to rid bacteria and then rocked in water at room temperature for 30 min to allow the gut to purge. Samples were pelleted, frozen on dry ice, and stored at –70°C until analyzed. Frozen C. elegans pellets were lyophilized before extraction. The resulting dry residue was not necessarily homogenous, and care was taken in removing aliquots for assay. In general, the entire pellet was dissolved in 1 M NaOH and centrifuged for 10 min at 10,000 rpm at 4°C. The supernatant was collected and the insoluble residue was reextracted at one-half volume. Both supernatants were pooled and stored frozen; the insoluble residue was rejected. For analysis of GlcNAcitol, alkaline β-elimination was performed and the product was analyzed by HPLC as described below. All, or aliquots, of the extract was passed over a P-2 column, 15 × 75 mm, (Bio-Rad) (21) and eluted in 0.02 M ammonium formate containing 0.02% NaN3 at room temperature. Fractions of ≈1 ml were collected every 3 min. To determine the location of various components, individual fraction were assayed on a Dionex HPLC equipped with a pulsed amperometric detector (model PAD 2) and pellicular anion exchange column (PA 10, 4 × 250 mm). Trehalose and monomeric glucose were assayed directly as above in 18 mM NaOH; fractions containing polymeric glucose (which we will term glycogen) were hydrolyzed at 100°C for 4 h in 2 M trifluoroacetic acid before being assayed. The identified fractions were pooled, lyophilized, and taken up in 1 ml of water for final carbohydrate determination. The limit of detection for the monosaccharides is ≈10–40 nmol·mg dry weight.
Nile Red and Carminic Acid Staining. Carminic acid was introduced into the WT N2 Bristol and KM258 ogt-1(ok430) worms through feeding. Specifically, OP50 bacterial cells were inoculated into LB broth containing 1 mg/ml carminic acid and grown overnight at room temperature. This culture was then used to prepare bacterial lawns on standard nematode growth media agar plates (21). Worms were transferred to the carminic acid containing lawns as young adults, and their progeny were analyzed at larval stage 4 or young adult stages. Nile red staining of mixed-stage embryos and adults was carried out as described (22).
Immunoblotting. Nematodes were dissolved in 10 vol of boiling SDS sample buffer. SDS/PAGE and transfer were performed as described (16).
Immunofluorescence. Embryos were permeabilized by freeze cracking and fixed in paraformaldehyde and methanol as described (23). Whole larvae and adults were fixed as described by Finney and Ruvkun (24). Primary Abs for RL-1 (IgM) and RL-2 (IgG) (Affinity BioReagents, Neshanic Station, NJ) and CeMyoD (HLH-1) (IgG) were diluted 1:400 and incubated with fixed specimens overnight at 4°C. After washing, 1:400 dilutions of fluorescently conjugated secondary Abs (Jackson Immunological, West Grove, PA) were applied for 2 h at room temperature. Specimens were washed and stained with DAPI before mounting.
Results
The ogt-1 deletion allele (ok430) was obtained from the C. elegans Knockout Consortium as a viable homozygote and was backcrossed four times before further study. The homozygous ogt-1(ok430) strain appeared phenotypically normal upon simple inspection. Sequencing the ogt-1(ok430) allele revealed a 1,094-bp deletion of ogt-1 and a 141-bp insertion resulting in an in-frame stop codon at the deletion break point. Sequencing ogt-1 cDNA products from WT and ogt-1(ok430) animals confirmed the predicted mRNA products. The predicted C. elegans OGT translation product in ogt-1(ok430) is a truncated 465-aa protein. The first 454 amino acids are from OGT-1, and 11 additional residues are added as a result of the genomic rearrangement before the first in-frame stop codon (Fig. 1A). It is unlikely that this altered transcript accumulates to significant levels because of nonsense-mediated decay that, in the worm, is regulated by the Smg system (25). Our previous studies suggest that, even if the aberrant message is translated, the trun-cated protein would not produce catalytically active enzyme (7), and we consider this allele to likely be a null. To directly measure O-GlcNAc levels, we monitored O-GlcNAcitol released after alkaline β-elimination (Fig. 1B). In N2, O-GlcNAcitol levels were ≈225 nmol/mg dry weight, whereas O-GlcNAcitol was undetectable (<40 nmol/mg dry weight) in ogt-1(ok430). We also carried out an Affymetrix GeneChip analysis for mixed stage populations of ogt-1(ok430) and N2 to assess global changes in transcription. The results suggested that the variations between the gene expression pattern derived from replicate RNA preparations were larger than differences between the strains, consistent with the lack of obvious phenotype.
To confirm that homozygous animals harboring the ogt-1(ok430) allele had lost the ability to transfer O-GlcNAc, we used two commercially available mAbs directed against nuclear pore antigens. The O-GlcNAc-specific Ab RL-2 recognizes O-GlcNAc-modified nucleoporins, whereas RL-1 recognizes nucleoporin protein determinants (26). Using immunoblotting, we analyzed the extracted proteins with both RL-1 and RL-2 in WT and ogt-1(ok430) mutant strains. Equal amounts of protein were loaded onto each gel lane (Fig. 1 C–E). As additional loading controls, blots were stained with Ponceau (Fig. 1 C–E Lower) before being analyzed by chemiluminescence (Fig. 1 C–E Upper). The anti-O-GlcNAc Ab RL-2 detected a number of apparently O-GlcNAc modified proteins in the WT extract ranging in molecular mass from ≈55 kDa to ≈150 kDa (Fig. 1C). These bands were not detected in ogt-1(ok430) protein extracts. As an internal loading control for the RL-2 experiments, we used RL-1, which binds to nucleoporin protein determinants. In contrast to the results with RL-2, nearly equivalent amounts of the nucleoporins were detected by using RL-1 in both strains (Fig. 1D). O-GlcNAc was also detected by using the O-GlcNAc Ab CTD110 (Fig. 1E) (27). Here again, bands were detectable in N2 but absent in ogt-1(ok430).
We confirmed these biochemical findings by immunofluorescence microscopy. As shown in Fig. 2A, indirect immunofluorescence localization with RL-2 revealed a perinuclear distribution of nucleoporins in WT embryos that was absent in ogt-1(ok430) embryos. The position of the nucleus is apparent from the DAPI staining shown below for each embryo. In contrast, as shown in Fig. 2B, immunofluorescence with RL-1 demonstrated the normal amount and distribution of nucleoporins in both WT and ogt-1(ok430) embryos. These data suggest that the nucleoporins in ogt-1(ok430) are present but are not modified by O-GlcNAc.
Previous work has suggested that O-GlcNAc addition to nuclear pores may play a role in nuclear transport (1, 2). For example, the lectin wheat germ agglutinin interferes with nuclear transport by binding to O-GlcNAc residues on nuclear pore proteins. To examine the effect of altered O-GlcNAc synthesis on nuclear pore function, we examined nuclear transport of several well characterized C. elegans transcription factors, including SKN-1, HLH-1, HLH-2, ELT-2, and LIN-26. In C. elegans, SKN-1 is involved in both early blastomere development and the stress response (28–31). The stress response in larvae and adults causes cytoplasmic SKN-1 in intestinal cells to rapidly translocate to the nucleus (28). We have used the intestinal nuclear translocation of SKN-1 in response to sodium azide-induced stress to assay nuclear transport in ogt-1(ok430) animals. In Fig. 3A, SKN-1::GFP expression and localization was monitored in a WT and ogt-1(ok430) background. As shown in Fig. 3A Left, sodium azide induces the rapid appearance of SKN-1::GFP in intestinal cell nuclei. When the same experiment was carried out in the ogt-1(ok430) mutant background (Fig. 3A Right), a translocation with similar kinetics was observed. These data suggest that the OGT-deficient nuclear pores in ogt-1(ok430) are capable of mediating normal rates of nuclear import. We also examined another transcription factor, HLH-1, that appears early in development in the nucleus of muscle precursor cells undergoing rapid cell divisions (23, 32). Here again, the nuclear localization of the transcription factor in early development was indistinguishable in WT and ogt-1(ok430) strains (Fig. 3B). Similar results were obtained for HLH-2, ELT-2, and LIN-26 (data not shown). These findings suggest that nuclear transport of transcription factors in ogt-1(ok430) was unaffected. Although we cannot exclude the possibility that O-GlcNAc modification is required for nuclear targeting of some transcription factors, the normal development of ogt-1(ok430) suggests that O-GlcNAc modification is not an essential component of the nuclear transport machinery.
The hexosamine pathway terminating in OGT has been suggested to play a role in mammalian insulin resistance. Mammalian insulin resistance involves changes in carbohydrate and fat metabolism in insulin target tissues that become less responsive to circulating insulin levels. In C. elegans, an insulin-like-signaling pathway plays key roles in aging, development, dauer formation, and storage of macronutrients in granules (33–40). We sought to determine whether changes in carbohydrates or lipids occur as a result of the ogt-1(ok430) deletion. We measured the levels of monosaccharides, trehalose, and glycogen in mixed populations of both the WT (N2) and ogt-1(ok430) (Fig. 4A Left). The ogt-1(ok430) mutant strain showed a dramatic (2- to 3-fold) elevation of both trehalose and glycogen stores (Fig. 4A). The sugar storage phenotype was also observed after RNAi of the ogt-1 locus in the N2 strain (1.6-fold). In contrast, RNAi of the ogt-1 locus in the ogt-1(ok430) deletion strain did not further increase sugar storage as anticipated for an ogt-1 null (both conditions ≈2.1-fold).
To determine the site of carbohydrate storage, we allowed C. elegans strains to take up carminic acid added to Escherichia coli as described in Materials and Methods. Carminic acid is a fluorescent derivative of glucose that binds to glycogen and trehalose (41, 42). As shown in Fig. 4A Right, stores of glycogen were readily visualized in the intestine by using carminic acid. Only a subset of the granules in intestinal cells were labeled, suggesting that glycogen storage is restricted to these structures in the gut. Other storage sites of glycogen storage may exist in C. elegans that were not labeled under these conditions.
To measure the storage of fat in the two strains, we performed a quantitative lipid analysis (see Materials and Methods). As shown in Fig. 4B Left, the results of several replicate experiments suggest that ogt-1(ok430) mutant animals stored only approximately one-third of the level of triglycerides observed in the N2 strain. Sterol esters were also reduced in ogt-1(ok430) mutant animals (data not shown). The site of accumulation of neutral lipids in both ogt-1(ok430) (Fig. 4B Right) and WT strains (data not shown) by using the fluorescent probe Nile red (5H-benzo-[a]-phenoxazine-5–1,9-diethylamino) was in a subset of granules in the intestine. These findings demonstrate a decrease in fat storage occurs in the absence of OGT activity. Decreased lipid storage is in contrast to the increase in carbohydrate stores observed in ogt-1(ok430) mutants (Fig. 4A).
The observed alteration in carbohydrate and lipid storage in ogt-1(ok430) suggested an alteration in insulin signaling. In nematodes, an insulin-like-signaling cascade is involved in macronutrient storage, longevity, and the transition to dauer (diapause) (Fig. 5A). Components of this pathway are conserved from nematodes to humans (33–40). To assess the impact of the ogt-1(ok430) null on insulin-like signaling, we crossed ogt-1(ok 430) to a strain harboring a temperature-sensitive constitutive mutation in daf-2, encoding an insulin-like receptor (67). As shown in Fig. 5B, we examined dauer development in N2, ogt-1(ok430), daf-2(e1370), and the ogt-1(ok430) daf-2(e1370) double mutant. Neither N2 nor ogt-1(ok430) produced dauers. In contrast, the daf-2 mutant produced nearly 100% dauers under these conditions. In the ogt-1(ok430) daf-2(e1370) strain, the formation of dauers was greatly reduced, demonstrating that ogt-1(ok430) is a genetic suppressor of dauer formation induced by the daf-2 ts allele. These data, coupled with the observed changes in macronutrient storage, implicate O-GlcNAc addition by OGT-1 in modulating insulin-like-signaling and/or parallel pathways regulating diapause in the nematode.
Discussion
OGT-1 Plays a Nonessential Regulatory Role in C. elegans. The isolation of a viable C. elegans strain lacking OGT activity allows a direct examination of the role of O-GlcNAc modification in the development and physiology of the nematode. Here we have demonstrated that nuclear pores in homozygous ogt-1(ok430) animals lacking O-GlcNAc are present in normal amounts and are capable of supporting normal nuclear transport of at least five transcription factors. We also observed no gross changes in the development of ogt-1(ok430) mutants. These findings are consistent with previous RNAi results from our own and other laboratories (7, 17, 18). Quite different results have been reported for OGT knockouts in mice where stem cell and embryonic lethality were observed (13, 14). The mice in the conditional knockout survive until embryonic day 8.5. The differences observed between the phenotypes in mammals and nematodes may be caused by the more complex nature of the mammalian gene. In C. elegans, we have reported the existence of a single gene, ogt-1 (7). Unlike the ogt-1-related genes in Arabidopsis [spindly and secret agent (43)], there is no evidence for redundancy of ogt-1 in the C. elegans genome (7). We have previously demonstrated the existence of multiple alternatively spliced transcripts in mouse and human that produce differentially targeted proteins (14). In C. elegans, the available ESTs suggest that only one isoform (corresponding to the nucleocytoplasmic OGT) is produced. Mammalian isoforms include 116-kDa nucleocytoplasmic OGT, the 78-kDa short OGT isoform, and the 103-kDa mitochondrially targeted isoform. The short OGT isoform has been implicated as an antiapoptotic gene in mammals (44). Another isoform is targeted to mitochondria and induces apoptosis when expressed in mammalian cells (D.C.L., S.H. Shin, and J.A.H., unpublished data). The pathway of apoptosis has been well characterized in C. elegans and involves a cascade of events resulting in caspase activation (45–47). The role of mitochondria in this process has been subject to much debate but may differ in detail from the mitochondrion's role in mammalian apoptosis (48–56). It is clear that absence of ogt-1 in C. elegans does not lead to a dramatic alteration in programmed cell death.
OGT-1 Modulates Dauer Formation and Macronutrient Storage. In this report, we have shown that an ogt-1 deletion allele suppresses dauer formation induced by the partial loss of function of daf-2, encoding an insulin-like receptor (Fig. 5). These data suggest that the hexosamine-signaling pathway terminating in OGT-1 may normally act to suppress insulin signaling in the nematode. In parallel findings, we have shown that the ogt-1(ok430) mutant strain, lacking OGT activity, has altered carbohydrate and lipid metabolism. Significantly higher levels of the circulating disaccharide trehalose and elevated glycogen stores are detected in ogt-1(ok430) mutants compared with WT animals. These findings are extremely interesting in light of the proposed function of OGT in nutrient-sensing pathways and the regulation of insulin signaling in mammals. Macronutrient storage occurs in the transition to dauer (diapause) in C. elegans in a process regulated by the insulin-like-signaling pathway (38). Furthermore, in mammals, the enzymes GSK-3β and glycogen synthase regulate glycogen stores downstream of insulin-signaling cascades (57–59). O-GlcNAc modification of glycogen synthase has been shown to inhibit the ability of the enzyme to catalyze glycogen formation. Several of the enzymes upstream of glycogen synthase, including GSK-3β, are also substrates for OGT (57–59). The sugar trehalose may be important in the physiology of nematodes where it functions in sugar transport, energy storage, and protection against environmental stress. Trehalose metabolism is catalyzed by trehalose-6-phosphate synthase and trehalose-6-phospate phosphatase, responsible for trehalose synthesis, and trehalase-catalyzing hydrolysis of the disaccharide. In C. elegans, the trehalase and trehalose-6-phosphate synthase genes are induced in daf-2 mutants and repressed by daf-16 (Forkhead transcription factor) RNAi (60). The ogt-1(ok430) mutant strain produces much higher levels of glycogen and trehalose than WT animals under normal culture conditions, suggesting that the absence of ogt-1 leads to deregulation of these metabolic pathways. It is likely that O-GlcNAc addition normally plays a role in nutrient sensing by detecting flux through the hexosamine-synthetic pathway. This study provides genetic evidence that the nematode hexosamine-signaling pathway interacts with the insulin-signaling pathway, as previous data has suggested in mammals (1–4). The insulin-signaling pathway is known to modulate lipid and carbohydrate storage in the nematode (38). With increased access to nutrients, a concomitant increase in O-GlcNAc modification would then serve to blunt insulin signaling. Based on what we know in mammals, the effects of the ogt-1(ok430) null in the nematode are also likely to include alteration of enzyme function, transcription, translation, and protein stability.
The decrease in neutral lipid storage in ogt-1(ok430) strongly suggests that alterations in cellular signaling accompany the knockout of OGT. Enzymes of lipid storage are transcriptionally responsive to the insulin-like-signaling pathways in C. elegans (22, 61–63), and elevated lipid storage occurs in dauer (64, 65). In humans, type 2 diabetes (noninsulin-dependent diabetes mellitus, adult onset) is characterized by elevated plasma fatty acids, which may result from unchecked lipolysis in adipose cells. In the nematode model provided by the ogt-1(ok430) mutant, it is not yet clear whether the lowered neutral lipid stores are caused by decreased synthesis of neutral lipids from nutrients or increased mobilization of triglycerides to form free fatty acids.
A Genetic Model of Insulin Resistance. The C. elegans strain lacking OGT-1 activity may provide a valuable tool for examining the role of O-GlcNAc addition in cellular function and human disease. For instance, the putative role of OGT in neurodegeneration may become accessible in the nematode. A nematode model of tauopathy and neurodegeneration has recently been described that will enable a dissection of the mechanism of neurodegeneration and the possible role of OGT in this process (66). We feel that the nematode may be a very useful model for examining the insulin resistance associated with noninsulin-dependent diabetes mellitus. OGT has been implicated in mammalian insulin resistance (1–4). We previously showed that OGT overexpression produces insulin resistance in transgenic mice (3). The present study suggests a modulation of dauer formation and macronutrient storage in the worm by OGT-1 that is analogous to metabolic changes associated with mammalian insulin resistance. In nematodes, dauer formation is influenced by insulin-signaling as well as parallel-signaling pathways (38). This genetic system offers clear advantages in sorting out the contribution of OGT and these other pathways to dauer formation. The interaction between the “hexosamine-signaling pathway” and the insulin-like signaling pathway may be amenable to genetic analysis.
Acknowledgments
We thank Othmar Gabriel for assistance with sugar nucleotide determination and carbohydrate analysis, Robert Littlejohn for technical help, and Drs. Eun Ju Kim and Brooke Lazarus for assistance with attempting to assay the nematode enzymes of O-GlcNAc addition.
Author contributions: J.A.H., G.A., and M.K. designed research; J.A.H., M.E.F., P.T.H., D.C.L., T.M.B., G.A., and M.K. performed research; J.A.H., G.A., and M.K. contributed new reagents/analytic tools; J.A.H., M.E.F., D.C.L., G.A., and M.K. analyzed data; and J.A.H. wrote the paper.
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: O-GlcNAc, O-linked N-acetylglucosamine; OGT, O-GlcNAc transferase; RNAi, RNA interference.
References
- 1.Hanover, J. A. (2001) FASEB J. 15, 1865–1876. [DOI] [PubMed] [Google Scholar]
- 2.Wells, L., Vosseller, K. & Hart, G. W. (2001) Science 291, 2376–2378. [DOI] [PubMed] [Google Scholar]
- 3.McClain, D. A., Lubas, W. A., Cooksey, R. C., Hazel, M., Parker, G. J., Love, D. C. & Hanover, J. A. (2002) Proc. Natl. Acad. Sci. USA 99, 10695–10699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Vosseller, K., Wells, L., Lane, M. D. & Hart, G. W. (2002) Proc. Natl. Acad. Sci. USA 99, 5313–5318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gao, Y., Wells, L., Comer, F. I., Parker, G. J. & Hart, G. W. (2001) J. Biol. Chem. 276, 9838–9845. [DOI] [PubMed] [Google Scholar]
- 6.Wells, L., Gao, Y., Mahoney, J. A., Vosseller, K., Chen, C., Rosen, A. & Hart, G. W. (2002) J. Biol. Chem. 277, 1755–1761. [DOI] [PubMed] [Google Scholar]
- 7.Lubas, W. A., Frank, D. W., Krause, M. & Hanover, J. A. (1997) J. Biol. Chem. 272, 9316–9324. [DOI] [PubMed] [Google Scholar]
- 8.Kreppel, L. K., Blomberg, M. A. & Hart, G. W. (1997) J. Biol. Chem. 272, 9308–9315. [DOI] [PubMed] [Google Scholar]
- 9.Swain, S. M., Tseng, T. S. & Olszewski, N. E. (2001) Plant Physiol. 126, 1174–1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Thornton, T. M., Swain, S. M. & Olszewski, N. E. (1999) Trends Plant Sci. 4, 424–428. [DOI] [PubMed] [Google Scholar]
- 11.Jinek, M., Rehwinkel, J., Lazarus, B. D., Izaurralde, E., Hanover, J. A. & Conti, E. (2004) Nat. Struct. Mol. Biol. 11, 1001–1007. [DOI] [PubMed] [Google Scholar]
- 12.Wrabl, J. O. & Grishin, N. V. (2001) J. Mol. Biol. 314, 365–374. [DOI] [PubMed] [Google Scholar]
- 13.Shafi, R., Iyer, S. P., Ellies, L. G., O'Donnell, N., Marek, K. W., Chui, D., Hart, G. W. & Marth, J. D. (2000) Proc. Natl. Acad. Sci. USA 97, 5735–5739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hanover, J. A., Yu, S., Lubas, W. B., Shin, S. H., Ragano-Caracciola, M., Kochran, J. & Love, D. C. (2003) Arch. Biochem. Biophys. 409, 287–297. [DOI] [PubMed] [Google Scholar]
- 15.O'Donnell, N., Zachara, N. E., Hart, G. W. & Marth, J. D. (2004) Mol. Cell. Biol. 24, 1680–1690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Love, D. C., Kochan, J., Cathey, R. L., Shin, S. H., Hanover, J. A. & Kochran, J. (2003) J. Cell Sci. 116, 647–654. [DOI] [PubMed] [Google Scholar]
- 17.Gonczy, P., Echeverri, C., Oegema, K., Coulson, A., Jones, S. J., Copley, R. R., Duperon, J., Oegema, J., Brehm, M., Cassin, E., et al. (2000) Nature 408, 331–336. [DOI] [PubMed] [Google Scholar]
- 18.Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le, B. N., Moreno, S., Sohrmann, M., et al. (2003) Nature 421, 231–237. [DOI] [PubMed] [Google Scholar]
- 19.Folch, J., Sloane, S. G. H. & Lees, M. (1957) J. Biol. Chem. 226, 497–509. [PubMed] [Google Scholar]
- 20.El Hamdy, A. H. (1993) J. High Res. Chromatogr. 16, 55. [Google Scholar]
- 21.Brenner, S. (1974) Genetics 77, 71–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ashrafi, K., Chang, F. Y., Watts, J. L., Fraser, A. G., Kamath, R. S., Ahringer, J. & Ruvkun, G. (2003) Nature 421, 268–272. [DOI] [PubMed] [Google Scholar]
- 23.Krause, M., Fire, A., Harrison, S. W., Priess, J. & Weintraub, H. (1990) Cell 63, 907–919. [DOI] [PubMed] [Google Scholar]
- 24.Finney, M. & Ruvkun, G. (1990) Cell 63, 895–905. [DOI] [PubMed] [Google Scholar]
- 25.Pulak, R. & Anderson, P. (1993) Genes Dev. 7, 1885–1897. [DOI] [PubMed] [Google Scholar]
- 26.Snow, C. M., Senior, A. & Gerace, L. (1987) J. Cell Biol. 104, 1143–1156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Comer, F. I., Vosseller, K., Wells, L., Accavitti, M. A. & Hart, G. W. (2001) Anal. Biochem. 293, 169–177. [DOI] [PubMed] [Google Scholar]
- 28.An, J. H. & Blackwell, T. K. (2003) Genes Dev. 17, 1882–1893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Carroll, A. S., Gilbert, D. E., Liu, X., Cheung, J. W., Michnowicz, J. E., Wagner, G., Ellenberger, T. E. & Blackwell, T. K. (1997) Genes Dev. 11, 2227–2238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Walker, A. K., See, R., Batchelder, C., Kophengnavong, T., Gronniger, J. T., Shi, Y. & Blackwell, T. K. (2000) J. Biol. Chem. 275, 22166–22171. [DOI] [PubMed] [Google Scholar]
- 31.Bowerman, B., Eaton, B. A. & Priess, J. R. (1992) Cell 68, 1061–1075. [DOI] [PubMed] [Google Scholar]
- 32.Krause, M. (1995) BioEssays 17, 219–228. [DOI] [PubMed] [Google Scholar]
- 33.Cypser, J. R. & Johnson, T. E. (2003) Biogerontology 4, 203–214. [DOI] [PubMed] [Google Scholar]
- 34.Dorman, J. B., Albinder, B., Shroyer, T. & Kenyon, C. (1995) Genetics 141, 1399–1406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Gottlieb, S. & Ruvkun, G. (1994) Genetics 137, 107–120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Holt, S. J. & Riddle, D. L. (2003) Mech. Ageing Dev. 124, 779–800. [DOI] [PubMed] [Google Scholar]
- 37.Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. (1993) Nature 366, 461–464. [DOI] [PubMed] [Google Scholar]
- 38.Kimura, K. D., Tissenbaum, H. A., Liu, Y. & Ruvkun, G. (1997) Science 277, 942–946. [DOI] [PubMed] [Google Scholar]
- 39.Rea, S. & Johnson, T. E. (2003) Dev. Cell 5, 197–203. [DOI] [PubMed] [Google Scholar]
- 40.Tissenbaum, H. A. & Ruvkun, G. (1998) Genetics 148, 703–717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Horobin, R. W. & Murgatroyd, L. B. (1971) Histochem. J. 3, 1–9. [DOI] [PubMed] [Google Scholar]
- 42.Rasimas, J. P., Berglund, K. A. & Blanchard, G. J. (1996) J. Phys. Chem. 100, 7220–7229. [Google Scholar]
- 43.Hartweck, L. M., Scott, C. L. & Olszewski, N. E. (2002) Genetics 161, 1279–1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Fletcher, B. S., Dragstedt, C., Notterpek, L. & Nolan, G. P. (2002) Leukemia 16, 1507–1518. [DOI] [PubMed] [Google Scholar]
- 45.Metzstein, M. M., Stanfield, G. M. & Horvitz, H. R. (1998) Trends Genet. 14, 410–416. [DOI] [PubMed] [Google Scholar]
- 46.Hengartner, M. O. (2001) Cell 104, 325–328. [DOI] [PubMed] [Google Scholar]
- 47.Kaufmann, S. H. & Hengartner, M. O. (2001) Trends Cell Biol. 11, 526–534. [DOI] [PubMed] [Google Scholar]
- 48.Adams, J. M. & Cory, S. (2002) Curr. Opin. Cell Biol. 14, 715–720. [DOI] [PubMed] [Google Scholar]
- 49.Adrain, C. & Martin, S. J. (2001) Trends Biochem. Sci. 26, 390–397. [DOI] [PubMed] [Google Scholar]
- 50.Parrish, J., Li, L., Klotz, K., Ledwich, D., Wang, X. & Xue, D. (2001) Nature 412, 90–94. [DOI] [PubMed] [Google Scholar]
- 51.Wang, X., Yang, C., Chai, J., Shi, Y. & Xue, D. (2002) Science 298, 1587–1592. [DOI] [PubMed] [Google Scholar]
- 52.Borner, C. & Monney, L. (1999) Cell Death Differ. 6, 497–507. [DOI] [PubMed] [Google Scholar]
- 53.Mignotte, B. & Vayssiere, J. L. (1998) Eur. J. Biochem. 252, 1–15. [DOI] [PubMed] [Google Scholar]
- 54.Gottlieb, R. A. (2000) FEBS Lett. 482, 6–12. [DOI] [PubMed] [Google Scholar]
- 55.Bloss, T. A., Witze, E. S. & Rothman, J. H. (2003) Nature 424, 1066–1071. [DOI] [PubMed] [Google Scholar]
- 56.Lee, S. S., Lee, R. Y., Fraser, A. G., Kamath, R. S., Ahringer, J. & Ruvkun, G. (2003) Nat. Genet. 33, 40–48. [DOI] [PubMed] [Google Scholar]
- 57.Parker, G., Taylor, R., Jones, D. & McClain, D. (2004) J. Biol. Chem. 279, 20636–20642. [DOI] [PubMed] [Google Scholar]
- 58.Parker, G. J., Lund, K. C., Taylor, R. P. & McClain, D. A. (2003) J. Biol. Chem. 278, 10022–10027. [DOI] [PubMed] [Google Scholar]
- 59.Lubas, W. A. & Hanover, J. A. (2000) J. Biol. Chem. 275, 10983–10988. [DOI] [PubMed] [Google Scholar]
- 60.Murphy, C. T., McCarroll, S. A., Bargmann, C. I., Fraser, A., Kamath, R. S., Ahringer, J., Li, H. & Kenyon, C. (2003) Nature 424, 277–283. [DOI] [PubMed] [Google Scholar]
- 61.Ambros, V. (2003) Cell 113, 673–676. [DOI] [PubMed] [Google Scholar]
- 62.Baehrecke, E. H. (2002) Nat. Rev. Mol. Cell. Biol. 3, 779–787. [DOI] [PubMed] [Google Scholar]
- 63.Chiang, S. H. & MacDougald, O. A. (2003) Trends Genet. 19, 523–525. [DOI] [PubMed] [Google Scholar]
- 64.Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A. & Ruvkun, G. (1997) Nature 389, 994–999. [DOI] [PubMed] [Google Scholar]
- 65.Sze, J. Y., Victor, M., Loer, C., Shi, Y. & Ruvkun, G. (2000) Nature 403, 560–564. [DOI] [PubMed] [Google Scholar]
- 66.Kraemer, B. C., Zhang, B., Leverenz, J. B., Thomas, J. H., Trojanowski, J. Q. & Schellenberg, G. D. (2003) Proc. Natl. Acad. Sci. USA 100, 9980–9985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Riddle, D. L. (1977) Stadler Genet. Symp. Ser. 9, 101–120. [Google Scholar]